Literature DB >> 7036761

Relationship between plasma antidepressant levels and clinical outcome for inpatients receiving imipramine.

G M Simpson, K L White, J L Boyd, T B Cooper, A Halaris, I C Wilson, E J Raman, E Ruther.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7036761     DOI: 10.1176/ajp.139.3.358

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  5 in total

1.  Plasma levels and clinical response with imipramine in a study comparing efficacy with mianserin and nomifensine.

Authors:  S A Montgomery; D Roy; S Wynne-Willson; C Robinson; D B Montgomery
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

2.  The role of S-mephenytoin 4'-hydroxylase in imipramine metabolism by human liver microsomes: a two-enzyme kinetic analysis of N-demethylation and 2-hydroxylation.

Authors:  K Chiba; A Saitoh; E Koyama; M Tani; M Hayashi; T Ishizaki
Journal:  Br J Clin Pharmacol       Date:  1994-03       Impact factor: 4.335

3.  Relationship between plasma desipramine levels and clinical outcome for RDC major depressive inpatients.

Authors:  G M Simpson; E H Pi; E Abdelmalek; J L Boyd; R S Carroll; T B Cooper; A Miller
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

Review 4.  Pharmacokinetic optimisation of therapy with newer antidepressants.

Authors:  P J Goodnick
Journal:  Clin Pharmacokinet       Date:  1994-10       Impact factor: 6.447

Review 5.  Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review.

Authors:  Mazda Adli; Christopher Baethge; Andreas Heinz; Nicolas Langlitz; Michael Bauer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-04-29       Impact factor: 5.760

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.